We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Based Models Outperform Human Experts at Identifying Ovarian Cancer in Ultrasound Images

By MedImaging International staff writers
Posted on 07 Jan 2025
Print article
Image: Artificial intelligence can improve ovarian cancer diagnoses (Photo courtesy of 123RF)
Image: Artificial intelligence can improve ovarian cancer diagnoses (Photo courtesy of 123RF)

Ovarian tumors are commonly found, often by chance. In many regions, there is a significant shortage of ultrasound specialists, which has raised concerns about unnecessary medical interventions and delayed cancer diagnoses. A new study, published in Nature Medicine, reveals that artificial intelligence (AI)-based models can outperform human experts in identifying ovarian cancer from ultrasound images.

In the international study led by Karolinska Institute (Solna, Sweden), researchers developed and validated neural network models that can distinguish between benign and malignant ovarian lesions. The AI was trained and tested on over 17,000 ultrasound images from 3,652 patients across 20 hospitals in eight countries. The researchers then compared the diagnostic performance of these AI models with a large group of both expert and less experienced ultrasound examiners. The results showed that the AI models achieved an accuracy rate of 86.3%, surpassing the experts' 82.6% and non-experts' 77.7%.

The AI models could also reduce the need for expert referrals. In a simulated triage scenario, the AI reduced the number of referrals by 63% and the misdiagnosis rate by 18%. This could lead to quicker and more cost-effective care for patients with ovarian lesions. Despite these promising results, the researchers emphasize the need for further studies to fully understand the clinical limitations and potential of the neural network models. They are currently conducting prospective clinical trials to assess the safety and effectiveness of the AI tool in daily clinical practice. Future research will also include a randomized multicenter study to evaluate its impact on patient management and healthcare costs.

“With continued research and development, AI-based tools can be an integral part of tomorrow’s healthcare, relieving experts and optimizing hospital resources, but we need to make sure that they can be adapted to different clinical environments and patient groups,” said Karolinska Institute’s Filip Christiansen who is the joint first author.

Portable Color Doppler Ultrasound Scanner
DCU10
Computed Tomography System
Aquilion ONE / INSIGHT Edition
3T MRI Scanner
MAGNETOM Cima.X
Digital Radiographic System
OMNERA 300M

Print article

Channels

Nuclear Medicine

view channel
Image: CD45-PET is a robust, non-invasive tool for imaging inflammation (Photo courtesy of 123RF)

Breakthrough Method Detects Inflammation in Body Using PET Imaging

Inflammation is an immune response that helps protect the body against disease. However, when inflammation becomes chronic and excessive, it can lead to various long-term conditions, including cardiovascular... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.